OBIO · Categories · Form 4

OBIO - SEC Form 4 insider transactions

Orchestra BioMed Holdings Inc. (OBIO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for OBIO

• 2d
  Large owner Rtw Investments, Lp exercised 1,250,032 in-the-money shares at a strike of $0.00 and sold $132 worth of shares (32 units at $4.13) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 35d
  SEC Form 4 filed by Sherman Darren

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 35d
  SEC Form 4 filed by Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 35d
  SEC Form 4 filed by Hochman David P

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  SEC Form 4 filed by Principal Accounting Officer Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  Officer Sherman Darren was granted 397,000 shares, increasing direct ownership by 47% to 1,237,569 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  Chief Financial Officer Taylor Andrew Lawrence was granted 181,000 shares, increasing direct ownership by 40% to 632,493 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  Officer Hochman David P was granted 504,000 shares, increasing direct ownership by 88% to 1,076,467 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 84d
  Director Cleary Chris covered exercise/tax liability with 676 shares, decreasing direct ownership by 2% to 36,901 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 84d
  SEC Form 4 filed by Officer Sherman Darren

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 119d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,452 shares, decreasing direct ownership by 0.76% to 451,493 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 119d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 241 shares, decreasing direct ownership by 1% to 18,885 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 119d
  Officer Sherman Darren covered exercise/tax liability with 5,588 shares, decreasing direct ownership by 0.66% to 840,569 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 140d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 8,670 shares, decreasing direct ownership by 2% to 454,945 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 140d
  Officer Hochman David P covered exercise/tax liability with 43,638 shares, decreasing direct ownership by 7% to 572,467 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 156d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,071 shares, decreasing direct ownership by 0.66% to 463,615 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 156d
  Officer Sherman Darren covered exercise/tax liability with 40,340 shares, decreasing direct ownership by 5% to 846,157 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 168d
  Officer Hochman David P covered exercise/tax liability with 6,566 shares, decreasing direct ownership by 0.54% to 607,822 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 224d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 203 shares, decreasing direct ownership by 1% to 19,126 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 224d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 16,102 shares, decreasing direct ownership by 3% to 466,686 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 224d
  Officer Hochman David P covered exercise/tax liability with 43,638 shares, decreasing direct ownership by 6% to 611,105 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 238d
  Officer Sherman Darren covered exercise/tax liability with 40,340 shares, decreasing direct ownership by 4% to 886,497 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Chief Financial Officer Taylor Andrew Lawrence was granted 80,000 shares, increasing direct ownership by 20% to 480,788 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Aryeh Jason was granted 15,000 shares, increasing direct ownership by 16% to 107,482 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Officer Sherman Darren was granted 120,000 shares, increasing direct ownership by 15% to 923,837 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Connealy Pamela Ann was granted 15,000 shares, increasing direct ownership by 44% to 48,711 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Mack John Prosper was granted 15,000 shares, increasing direct ownership by 59% to 40,286 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Fain Eric S was granted 15,000 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Cleary Chris was granted 15,000 shares, increasing direct ownership by 66% to 37,577 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Officer Hochman David P was granted 200,000 shares, increasing direct ownership by 18% to 645,460 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Pacitti David was granted 15,000 shares, increasing direct ownership by 50% to 44,968 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Principal Accounting Officer Aiello Joshua was granted 15,000 shares, increasing direct ownership by 347% to 19,329 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 268d
  SEC Form 4 filed by Large owner Rtw Investments, Lp

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 308d
  Director Fain Eric S sold $8,183 worth of shares (2,683 units at $3.05) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 308d
  Director Aryeh Jason was granted 12,422 shares, increasing direct ownership by 16% to 92,482 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Cleary Chris was granted 12,422 shares, increasing direct ownership by 122% to 22,577 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Mack John Prosper was granted 12,422 shares, increasing direct ownership by 97% to 25,286 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Connealy Pamela Ann was granted 12,422 shares, increasing direct ownership by 58% to 33,711 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Fain Eric S was granted 12,422 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Pacitti David was granted 12,422 shares, increasing direct ownership by 71% to 29,968 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 315d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 393 shares, decreasing direct ownership by 8% to 4,329 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 322d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 28,172 shares, decreasing direct ownership by 7% to 400,788 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 322d
  Officer Hochman David P covered exercise/tax liability with 39,709 shares, decreasing direct ownership by 6% to 545,460 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 336d
  Officer Sherman Darren covered exercise/tax liability with 45,843 shares, decreasing direct ownership by 5% to 803,837 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  Officer Hochman David P was granted 98,333 shares, increasing direct ownership by 20% to 579,498 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  SEC Form 4 filed by Principal Accounting Officer Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  Officer Sherman Darren was granted 115,708 shares, increasing direct ownership by 16% to 849,680 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  Chief Financial Officer Taylor Andrew Lawrence was granted 84,000 shares, increasing direct ownership by 24% to 428,960 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 399d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 278 shares, decreasing direct ownership by 6% to 4,722 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 420d
  Officer Hochman David P covered exercise/tax liability with 80,080 shares, decreasing direct ownership by 14% to 499,418 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 450d
  Director Cleary Chris was granted 10,155 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 487d
  Director Aryeh Jason exercised 11,700 shares at a strike of $4.30, increasing direct ownership by 17% to 80,060 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 504d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 34,403 shares, decreasing direct ownership by 9% to 343,960 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 511d
  Officer Sherman Darren covered exercise/tax liability with 31,815 shares, decreasing direct ownership by 4% to 733,972 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 598d
  Officer Sherman Darren sold $73,946 worth of shares (13,708 units at $5.39), decreasing direct ownership by 2% to 765,787 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 598d
  Director Fain Eric S sold $30,666 worth of shares (5,600 units at $5.48) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 602d
  Officer Sherman Darren sold $120,955 worth of shares (20,617 units at $5.87), decreasing direct ownership by 3% to 779,495 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 631d
  Director Mack John Prosper was granted 12,864 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 632d
  Large owner Hsac 2 Holdings, Llc disposed of 3,405,251 shares, decreasing direct ownership by 67% to 1,705,705 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 679d
  Director Connealy Pamela Ann was granted 5,376 shares, increasing direct ownership by 34% to 21,289 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)

Other OBIO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends